Conference Call Scheduled for 4:30 pm Eastern Time on August 7th
NASDAQ, TSX: NVCN
VANCOUVER, Aug. 2, 2019 /CNW/ - Neovasc, Inc.
("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), a leader in the
development of minimally invasive transcatheter mitral valve
replacement technologies and in the development of minimally
invasive devices for the treatment of refractory angina, today
announced that it will report financial results for the quarter
ended June 30, 2019 and host a
conference call and webcast at 4:30 pm
Eastern Time on Wednesday August 7, 2019.
Conference Call & Webcast
Wednesday, August 7th @
4:30 pm Eastern Time
Domestic:
|
877-407-9208
|
International:
|
201-493-6784
|
Passcode:
|
13692456
|
Webcast:
|
http://public.viavid.com/index.php?id=135275
|
A replay of the event will be available via webcast through
August 21st on the
Company's website, www.neovasc.com, or at
http://public.viavid.com/index.php?id=135275.
About Neovasc Inc.
Neovasc is a specialty
medical device company that develops, manufactures and markets
products for the rapidly growing cardiovascular marketplace. Its
products include the Reducer, for the treatment of refractory
angina, which is not currently commercially available in
the United States and has been
commercially available in Europe
since 2015, and the Tiara™, for the transcatheter treatment of
mitral valve disease, which is currently under clinical
investigation in the United
States, Canada and
Europe. For more information,
visit: www.neovasc.com.
View original
content:http://www.prnewswire.com/news-releases/neovasc-to-announce-second-quarter-2019-financial-results-on-wednesday-august-7th-300895448.html
SOURCE Neovasc Inc.